 | • レポートコード：GIR201100608 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アミロイドーシス治療の世界市場を調査対象にし、アミロイドーシス治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AG-10、ALN-ANG、ALN-TTRsc02、CAEL-101、カナキヌマブ、その他）、用途別分析（ALアミロイドーシス、AAアミロイドーシス、ATTRアミロイドーシス、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer Inc.、Millennium Pharmaceuticals, Inc.、Arcturus Therapeutics, Inc、ProteoTech, Inc.、Celgene Corporation、Alnylam Pharmaceuticals, Inc.、GlaxoSmithKline Plc、Bsim2、Bellus Health Inc.、Onyx Pharmaceuticals, Inc.、Isis Pharmaceuticals, Inc.、Prothena Corporation Plc、SOM Innovation Biotech SL ・メーカー別販売量、売上、市場シェア ・アミロイドーシス治療の地域別市場分析 ・アミロイドーシス治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アミロイドーシス治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アミロイドーシス治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アミロイドーシス治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アミロイドーシス治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アミロイドーシス治療の種類別市場規模2015-2020：AG-10、ALN-ANG、ALN-TTRsc02、CAEL-101、カナキヌマブ、その他 ・アミロイドーシス治療の用途別市場規模2015-2020：ALアミロイドーシス、AAアミロイドーシス、ATTRアミロイドーシス、その他 ・アミロイドーシス治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Amyloidosis Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Amyloidosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Amyloidosis Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Amyloidosis Therapeutics market has been segmented into
AG-10
ALN-ANG
ALN-TTRsc02
CAEL-101
canakinumab
Others
By Application, Amyloidosis Therapeutics has been segmented into:
AL amyloidosis
AA amyloidoses
ATTR amyloidoses
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Amyloidosis Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Amyloidosis Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Amyloidosis Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Amyloidosis Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Amyloidosis Therapeutics Market Share Analysis
Amyloidosis Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Amyloidosis Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Amyloidosis Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Amyloidosis Therapeutics are:
Pfizer Inc.
Millennium Pharmaceuticals, Inc.
Arcturus Therapeutics, Inc
ProteoTech, Inc.
Celgene Corporation
Alnylam Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Bsim2
Bellus Health Inc.
Onyx Pharmaceuticals, Inc.
Isis Pharmaceuticals, Inc.
Prothena Corporation Plc
SOM Innovation Biotech SL
Among other players domestic and global, Amyloidosis Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amyloidosis Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amyloidosis Therapeutics, with price, sales, revenue and global market share of Amyloidosis Therapeutics in 2018 and 2019.
Chapter 3, the Amyloidosis Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amyloidosis Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Amyloidosis Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Amyloidosis Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Amyloidosis Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amyloidosis Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AG-10
1.2.3 ALN-ANG
1.2.4 ALN-TTRsc02
1.2.5 CAEL-101
1.2.6 canakinumab
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Amyloidosis Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 AL amyloidosis
1.3.3 AA amyloidoses
1.3.4 ATTR amyloidoses
1.3.5 Others
1.4 Overview of Global Amyloidosis Therapeutics Market
1.4.1 Global Amyloidosis Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer Inc. SWOT Analysis
2.1.4 Pfizer Inc. Product and Services
2.1.5 Pfizer Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Millennium Pharmaceuticals, Inc.
2.2.1 Millennium Pharmaceuticals, Inc. Details
2.2.2 Millennium Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Millennium Pharmaceuticals, Inc. SWOT Analysis
2.2.4 Millennium Pharmaceuticals, Inc. Product and Services
2.2.5 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Arcturus Therapeutics, Inc
2.3.1 Arcturus Therapeutics, Inc Details
2.3.2 Arcturus Therapeutics, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Arcturus Therapeutics, Inc SWOT Analysis
2.3.4 Arcturus Therapeutics, Inc Product and Services
2.3.5 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 ProteoTech, Inc.
2.4.1 ProteoTech, Inc. Details
2.4.2 ProteoTech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ProteoTech, Inc. SWOT Analysis
2.4.4 ProteoTech, Inc. Product and Services
2.4.5 ProteoTech, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene Corporation
2.5.1 Celgene Corporation Details
2.5.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Celgene Corporation SWOT Analysis
2.5.4 Celgene Corporation Product and Services
2.5.5 Celgene Corporation Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Alnylam Pharmaceuticals, Inc.
2.6.1 Alnylam Pharmaceuticals, Inc. Details
2.6.2 Alnylam Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Alnylam Pharmaceuticals, Inc. SWOT Analysis
2.6.4 Alnylam Pharmaceuticals, Inc. Product and Services
2.6.5 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline Plc
2.7.1 GlaxoSmithKline Plc Details
2.7.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline Plc SWOT Analysis
2.7.4 GlaxoSmithKline Plc Product and Services
2.7.5 GlaxoSmithKline Plc Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bsim2
2.8.1 Bsim2 Details
2.8.2 Bsim2 Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bsim2 SWOT Analysis
2.8.4 Bsim2 Product and Services
2.8.5 Bsim2 Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bellus Health Inc.
2.9.1 Bellus Health Inc. Details
2.9.2 Bellus Health Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bellus Health Inc. SWOT Analysis
2.9.4 Bellus Health Inc. Product and Services
2.9.5 Bellus Health Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Onyx Pharmaceuticals, Inc.
2.10.1 Onyx Pharmaceuticals, Inc. Details
2.10.2 Onyx Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Onyx Pharmaceuticals, Inc. SWOT Analysis
2.10.4 Onyx Pharmaceuticals, Inc. Product and Services
2.10.5 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Isis Pharmaceuticals, Inc.
2.11.1 Isis Pharmaceuticals, Inc. Details
2.11.2 Isis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Isis Pharmaceuticals, Inc. SWOT Analysis
2.11.4 Isis Pharmaceuticals, Inc. Product and Services
2.11.5 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Prothena Corporation Plc
2.12.1 Prothena Corporation Plc Details
2.12.2 Prothena Corporation Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Prothena Corporation Plc SWOT Analysis
2.12.4 Prothena Corporation Plc Product and Services
2.12.5 Prothena Corporation Plc Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 SOM Innovation Biotech SL
2.13.1 SOM Innovation Biotech SL Details
2.13.2 SOM Innovation Biotech SL Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 SOM Innovation Biotech SL SWOT Analysis
2.13.4 SOM Innovation Biotech SL Product and Services
2.13.5 SOM Innovation Biotech SL Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Amyloidosis Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Amyloidosis Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Amyloidosis Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Amyloidosis Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Amyloidosis Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Amyloidosis Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Amyloidosis Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Amyloidosis Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Amyloidosis Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Amyloidosis Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Amyloidosis Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Amyloidosis Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Amyloidosis Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Amyloidosis Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Amyloidosis Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Amyloidosis Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Amyloidosis Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Amyloidosis Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Amyloidosis Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Amyloidosis Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Amyloidosis Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Amyloidosis Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Amyloidosis Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Amyloidosis Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Amyloidosis Therapeutics Price by Type (2015-2020)
11 Global Amyloidosis Therapeutics Market Segment by Application
11.1 Global Amyloidosis Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Amyloidosis Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Amyloidosis Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Amyloidosis Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Amyloidosis Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Amyloidosis Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Amyloidosis Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Amyloidosis Therapeutics Market Forecast (2021-2025)
12.2.4 South America Amyloidosis Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Amyloidosis Therapeutics Market Forecast (2021-2025)
12.3 Amyloidosis Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Amyloidosis Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Amyloidosis Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Amyloidosis Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Amyloidosis Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Amyloidosis Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Amyloidosis Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Amyloidosis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Amyloidosis Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Inc. Amyloidosis Therapeutics Major Business
Table 9. Pfizer Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer Inc. SWOT Analysis
Table 11. Pfizer Inc. Amyloidosis Therapeutics Product and Services
Table 12. Pfizer Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Millennium Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Major Business
Table 15. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 16. Millennium Pharmaceuticals, Inc. SWOT Analysis
Table 17. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product and Services
Table 18. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Arcturus Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Major Business
Table 21. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 22. Arcturus Therapeutics, Inc SWOT Analysis
Table 23. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product and Services
Table 24. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. ProteoTech, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. ProteoTech, Inc. Amyloidosis Therapeutics Major Business
Table 27. ProteoTech, Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 28. ProteoTech, Inc. SWOT Analysis
Table 29. ProteoTech, Inc. Amyloidosis Therapeutics Product and Services
Table 30. ProteoTech, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Celgene Corporation Amyloidosis Therapeutics Major Business
Table 33. Celgene Corporation Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 34. Celgene Corporation SWOT Analysis
Table 35. Celgene Corporation Amyloidosis Therapeutics Product and Services
Table 36. Celgene Corporation Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Alnylam Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Major Business
Table 39. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 40. Alnylam Pharmaceuticals, Inc. SWOT Analysis
Table 41. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product and Services
Table 42. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Plc Amyloidosis Therapeutics Major Business
Table 45. GlaxoSmithKline Plc Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 46. GlaxoSmithKline Plc SWOT Analysis
Table 47. GlaxoSmithKline Plc Amyloidosis Therapeutics Product and Services
Table 48. GlaxoSmithKline Plc Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bsim2 Basic Information, Manufacturing Base and Competitors
Table 50. Bsim2 Amyloidosis Therapeutics Major Business
Table 51. Bsim2 Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 52. Bsim2 SWOT Analysis
Table 53. Bsim2 Amyloidosis Therapeutics Product and Services
Table 54. Bsim2 Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bellus Health Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Bellus Health Inc. Amyloidosis Therapeutics Major Business
Table 57. Bellus Health Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 58. Bellus Health Inc. SWOT Analysis
Table 59. Bellus Health Inc. Amyloidosis Therapeutics Product and Services
Table 60. Bellus Health Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Onyx Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Major Business
Table 63. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 64. Onyx Pharmaceuticals, Inc. SWOT Analysis
Table 65. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product and Services
Table 66. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Isis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Major Business
Table 69. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 70. Isis Pharmaceuticals, Inc. SWOT Analysis
Table 71. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product and Services
Table 72. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Prothena Corporation Plc Basic Information, Manufacturing Base and Competitors
Table 74. Prothena Corporation Plc Amyloidosis Therapeutics Major Business
Table 75. Prothena Corporation Plc Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 76. Prothena Corporation Plc SWOT Analysis
Table 77. Prothena Corporation Plc Amyloidosis Therapeutics Product and Services
Table 78. Prothena Corporation Plc Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. SOM Innovation Biotech SL Basic Information, Manufacturing Base and Competitors
Table 80. SOM Innovation Biotech SL Amyloidosis Therapeutics Major Business
Table 81. SOM Innovation Biotech SL Amyloidosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 82. SOM Innovation Biotech SL SWOT Analysis
Table 83. SOM Innovation Biotech SL Amyloidosis Therapeutics Product and Services
Table 84. SOM Innovation Biotech SL Amyloidosis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Amyloidosis Therapeutics Sales by Manufacturer (2018-2019) (K Pcs)
Table 86. Global Amyloidosis Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Amyloidosis Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 88. Global Amyloidosis Therapeutics Sales Market Share by Regions (2015-2020)
Table 89. Global Amyloidosis Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Amyloidosis Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 91. North America Amyloidosis Therapeutics Sales Market Share by Countries (2015-2020)
Table 92. North America Amyloidosis Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Amyloidosis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 94. Europe Amyloidosis Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 95. Europe Amyloidosis Therapeutics Sales Market Share by Countries (2015-2020)
Table 96. Europe Amyloidosis Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Amyloidosis Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 98. Asia-Pacific Amyloidosis Therapeutics Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Amyloidosis Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Amyloidosis Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 101. South America Amyloidosis Therapeutics Sales Market Share by Countries (2015-2020)
Table 102. South America Amyloidosis Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Amyloidosis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Amyloidosis Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 105. Middle East & Africa Amyloidosis Therapeutics Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Amyloidosis Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Amyloidosis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 108. Global Amyloidosis Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 109. Global Amyloidosis Therapeutics Sales Share by Type (2015-2020)
Table 110. Global Amyloidosis Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 111. Global Amyloidosis Therapeutics Revenue Share by Type (2015-2020)
Table 112. Global Amyloidosis Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 113. Global Amyloidosis Therapeutics Sales Share by Application (2015-2020)
Table 114. Global Amyloidosis Therapeutics Sales Forecast by Regions (2021-2025) (K Pcs)
Table 115. Global Amyloidosis Therapeutics Market Share Forecast by Regions (2021-2025)
Table 116. Global Amyloidosis Therapeutics Sales Forecast by Type (2021-2025) (K Pcs)
Table 117. Global Amyloidosis Therapeutics Market Share Forecast by Type (2021-2025)
Table 118. Global Amyloidosis Therapeutics Sales Forecast by Application (2021-2025)
Table 119. Global Amyloidosis Therapeutics Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Amyloidosis Therapeutics Picture
Figure 2. Global Sales Market Share of Amyloidosis Therapeutics by Type in 2019
Figure 3. AG-10 Picture
Figure 4. ALN-ANG Picture
Figure 5. ALN-TTRsc02 Picture
Figure 6. CAEL-101 Picture
Figure 7. canakinumab Picture
Figure 8. Others Picture
Figure 9. Amyloidosis Therapeutics Sales Market Share by Application in 2018
Figure 10. AL amyloidosis Picture
Figure 11. AA amyloidoses Picture
Figure 12. ATTR amyloidoses Picture
Figure 13. Others Picture
Figure 14. Global Amyloidosis Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Amyloidosis Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Amyloidosis Therapeutics Sales Market Share by Manufacturer in 2019
Figure 35. Global Amyloidosis Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Amyloidosis Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Amyloidosis Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Amyloidosis Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Amyloidosis Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 42. Global Amyloidosis Therapeutics Revenue Market Share by Regions in 2018
Figure 43. North America Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Europe Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
Figure 46. South America Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Amyloidosis Therapeutics Sales and Growth Rate (2015-2020)
Figure 48. North America Amyloidosis Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Amyloidosis Therapeutics Sales Market Share by Countries (2015-2020)
Figure 50. North America Amyloidosis Therapeutics Sales Market Share by Countries in 2018
Figure 51. North America Amyloidosis Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Amyloidosis Therapeutics Revenue Market Share by Countries in 2018
Figure 53. United States Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Amyloidosis Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Amyloidosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Amyloidosis Therapeutics Revenue Market Share by Countries in 2019
Figure 59. Germany Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Amyloidosis Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Amyloidosis Therapeutics Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Amyloidosis Therapeutics Revenue Market Share by Regions 2019
Figure 67. China Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Amyloidosis Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Amyloidosis Therapeutics Sales Market Share by Countries in 2019
Figure 74. South America Amyloidosis Therapeutics Revenue Market Share by Countries in 2019
Figure 75. Brazil Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Amyloidosis Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Amyloidosis Therapeutics Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Amyloidosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Amyloidosis Therapeutics Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Amyloidosis Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Amyloidosis Therapeutics Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Amyloidosis Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Amyloidosis Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Amyloidosis Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Amyloidosis Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Amyloidosis Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Amyloidosis Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
カナバン病治療薬の世界市場 2020年 Market Overview The global Canavan Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canavan Disease …- 増殖性硝子体網膜症（PVR）治療の世界市場 2020年 Market Overview The global Proliferative Vitreoretinopathy (PVR) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…
- 子宮頸部ジストニア治療の世界市場 2020年 Market Overview The global Cervical Dystonia Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cervical Dysto…
- 糖鎖生物学（診断及び治療）の世界市場 2020年 Market Overview The global Glycobiology (Diagnostics and Therapeutics) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The G…
- 抗体療法及び血液抗体療法の世界市場 2020年 Market Overview The Antibody Therapeutics and Blood Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pl…